Tag:

Pfizer

Latest Headlines

Latest Headlines

Pfizer shuttering vitamin C plant in California, 70 workers out of jobs

Several years ago, Pfizer added California-based Alacer to its consumer health business. But now it has decided it doesn't need a plant in California that came with that deal and will close it in May, laying off the 70 workers there.

Startup Akili partners with nonprofit Autism Speaks to test video game

Akili Interactive Labs has partnered with the nonprofit Autism Speaks to conduct a clinical trial of its cognitive assessment and personalized treatment video game.

Pfizer: Our IT systems are subject to frequent attacks

Pfizer has updated the risk factors section of its U.S. Securities and Exchange Commission (SEC) filings to reflect the new normal in cybersecurity. The Big Pharma lays out the situation plainly: "As a global pharmaceutical company, our systems are subject to frequent attacks."

Pfizer, Novartis: CDC's MenB nod is too narrow

Pfizer and Novartis have snagged a nod from the CDC's Advisory Committee on Immunization Practices for their recently approved meningitis B vaccines. There's just one problem: It doesn't cover nearly as large a population as the pharma giants would like.

From the pharma C-suite: Notable, quotable remarks on Asia, emerging markets (Part 2)

Here is part two of comments from C-suite execs on emerging markets and Asia in the latest quarterly conference calls.

Pfizer, Novartis get MenB ACIP nod--but not the one they're really after

Pfizer and Novartis officially have a nod from the CDC's Advisory Committee on Immunization Practices (ACIP) for their recently approved meningitis B vaccines. Problem is, it doesn't cover nearly as large a population as the pharma giants would like.

Exclusive: Pfizer is once again cutting back R&D staff in reorganization

Pfizer is once again trimming its R&D staff. Responding to a query from FierceBiotech regarding word of cutbacks at research facilities in Cambridge, MA, and Collegeville, PA, Pfizer spokesman Dean Mastrojohn sent back a confirmation, later declining to specify just how many jobs are being cut.

Pfizer trumpets positive Trumenba data ahead of ACIP vote

Pfizer may have FDA approval for meningitis B vaccine Trumenba, but it can only take the jab so far without a nod from the CDC's Advisory Committee on Immunization Practices (ACIP). Now, though, it's got some positive new data on the shot just in time to help it make its case for one.

Can Pfizer's new breast cancer med really cruise to $4B and beyond?

An early FDA approval is a bonus for any drug. But for Pfizer's new breast cancer drug Ibrance (palbociclib), the earlier-than-expected green light has given it a billion-dollar-plus boost--on paper, anyway.

To Pfizer's Chantix, a new JAMA study sounds like 14M potential patients

In a study published in JAMA on Tuesday, researchers said Chantix helped smokers who'd like to stop but weren't yet ready to quit get serious about the idea. The study authors estimated that 14 million current smokers fit the same profile as the study participants. That's a lot of potential new patients.